| RS2063918355 |
SNRNP200
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 33, SNRNP200-related disorder |
| RS2063918440 |
SNRNP200
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2063918625 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2063922414 |
DDX3X
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2063922977 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2063923221 |
DDX3X
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2063923605 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS2063923749 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS2063923789 |
DDX3X
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 102 |
| RS2063927503 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS2063927827 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2063927856 |
DDX3X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 102 |
| RS2063928003 |
DDX3X
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2063928899 |
DDX3X
|
Health Risk |
Pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS2063932925 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS2063933550 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS2063933817 |
DDX3X
|
Health Risk |
Pathogenic |
Global developmental delay, Microcephaly |
| RS2063939905 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, Inborn genetic diseases |
| RS2063940085 |
DDX3X
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2063940433 |
DDX3X
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2063941013 |
DDX3X
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2063984022 |
OTUD5
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-neurodevelopmental syndrome, X-linked |
| RS2064030791 |
TRIM8
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis and neurodevelopmental syndrome, Focal segmental glomerulosclerosis and neurodevelopmental syndrome |
| RS2064030858 |
TRIM8
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Focal segmental glomerulosclerosis |
| RS2064032086 |
TRIM8
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis and neurodevelopmental syndrome, Focal segmental glomerulosclerosis and neurodevelopmental syndrome |
| RS2064035939 |
SNAP25
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2064043746 |
CEP250
|
Health Risk |
Pathogenic |
Cone-rod dystrophy and hearing loss 2, Cone-rod dystrophy and hearing loss 2 |
| RS2064048389 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2064077764 |
CEP250
|
Health Risk |
Pathogenic |
Cone-rod dystrophy and hearing loss 2, Cone-rod dystrophy and hearing loss 2 |
| RS2064092893 |
CEP250
|
Health Risk |
Pathogenic |
Cone-rod dystrophy and hearing loss 2, Cone-rod dystrophy and hearing loss 2 |
| RS2064136104 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2064208424 |
SCN1B
|
Health Risk |
Pathogenic |
Brugada syndrome 5, Brugada syndrome 5 |
| RS2064208734 |
SCN1B
|
Health Risk |
Likely pathogenic |
Brugada syndrome 5, Brugada syndrome 5 |
| RS2064221873 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Cardiovascular phenotype |
| RS2064222084 |
SCN1B
|
Health Risk |
Pathogenic |
Brugada syndrome 5, Brugada syndrome 5 |
| RS2064230124 |
SCN1B
|
Health Risk |
Pathogenic |
Brugada syndrome 5, Brugada syndrome 5 |
| RS2064260290 |
BTD
|
Health Risk |
Pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS2064304102 |
ARL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2064345759 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2064346850 |
NHS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Nance-Horan syndrome |
| RS2064355122 |
SNAP25
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 18, Developmental and epileptic encephalopathy |
| RS2064355563 |
SNAP25
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 18, Developmental and epileptic encephalopathy |
| RS2064376489 |
NYX
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2064376509 |
NYX
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1A, Congenital stationary night blindness 1A |
| RS2064378728 |
NYX
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2064439011 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2064448593 |
TUBGCP6
|
Health Risk |
Likely pathogenic |
— |
| RS2064466448 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2064470709 |
TUBGCP6
|
Health Risk |
Likely pathogenic |
Microcephaly and chorioretinopathy 1, Microcephaly and chorioretinopathy 1 |
| RS2064482125 |
TUBGCP6
|
Health Risk |
Likely pathogenic |
— |
| RS2064500789 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2064507825 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2064509262 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2064598729 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2064682269 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2064684700 |
SCN11A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory and autonomic neuropathy type 7, Familial episodic pain syndrome with predominantly lower limb involvement |
| RS2064686873 |
L1CAM
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2064692244 |
L1CAM
|
Health Risk |
Likely pathogenic |
L1 syndrome, L1 syndrome |
| RS2064692485 |
L1CAM
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2064703218 |
L1CAM
|
Health Risk |
Pathogenic |
L1 syndrome, L1 syndrome |
| RS2064704974 |
L1CAM
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2064712705 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2064715459 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2064716137 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS2064717485 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2064727120 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2064733634 |
ZNF408
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS2064735979 |
COL13A1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 19, Congenital myasthenic syndrome 19 |
| RS2064742830 |
TFE3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2064742925 |
TFE3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Neurodevelopmental abnormality |
| RS2064747653 |
L1CAM
|
Health Risk |
Likely pathogenic |
MASA syndrome, MASA syndrome |
| RS2064752971 |
MPI
|
Health Risk |
Conflicting classifications of pathogenicity |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2064754424 |
MPI
|
Health Risk |
Pathogenic/Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2064763561 |
L1CAM
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2064766332 |
L1CAM
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2064782292 |
L1CAM
|
Health Risk |
Likely pathogenic |
X-linked hydrocephalus syndrome, X-linked hydrocephalus syndrome |
| RS2064809181 |
L1CAM
|
Health Risk |
Likely pathogenic |
MASA syndrome, MASA syndrome |
| RS2064828055 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2064832233 |
MPI
|
Health Risk |
Likely pathogenic |
— |
| RS2064836017 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2064839839 |
MPI
|
Health Risk |
Pathogenic/Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2064840759 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2064840907 |
MPI
|
Health Risk |
Conflicting classifications of pathogenicity |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2064843052 |
MPI
|
Health Risk |
Conflicting classifications of pathogenicity |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2064850147 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2064851971 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2064852005 |
MKKS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2064860460 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS2064862256 |
UNC13D
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS2064876977 |
F2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital prothrombin deficiency, Congenital prothrombin deficiency |
| RS2064882892 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS2064886777 |
F2
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital prothrombin deficiency, Congenital prothrombin deficiency |
| RS2064886794 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2064887539 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2064896365 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2064897275 |
MKKS
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome |
| RS2064897670 |
MKKS
|
Health Risk |
Pathogenic/Likely pathogenic |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome |
| RS2064899680 |
AP4E1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 51, Hereditary spastic paraplegia 51 |
| RS2064902750 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2064903228 |
MKKS
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |